New Drug Approvals

MAY 20, 2025

PMID 39239035.

FDA Approval 62

FDA Approval FDA Disease Treatment 62

New Drug Approvals

MAY 26, 2025

External links Clinical trial number NCT04186819 for “Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) Flotufolastat F 18 Flotufolastat F-18 Gallium POSLUMA CAS 2305081-64-3 18FrhPSMA-7.3 18F-rhPSMA-7.3 1] The active ingredient is flotufolastat ( 18 F). [1] 1] [2] SYNTHESIS Bejot, R.,

Clinical Trials 62

Clinical Trials FDA FDA Approval Trials 62

New Drug Approvals

APRIL 27, 2025

octane-8,1′-azolidin-1-ium]-3-yl 2-hydroxy-2,2-diphenylacetate;chloride FDA 2024, Cobenfy 9/26/2024, To treat schizophrenia Press Release Drug Trials Snapshot Trospium chloride is a muscarinic antagonist used to treat overactive bladder. [3] decane chloride 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-8lambda5-azaspiro[bicyclo[3.2.1]octane-8,1′-pyrrolidin]-8-yliumchloride

FDA Approval 57

FDA Approval FDA Pharmacokinetics Licensing 57

New Drug Approvals

APRIL 13, 2025

Olezarsen FDA APPROVED 12/19/2024, Tryngolza , To treat familial chylomicronemia syndrome Drug Trials Snapshot Synonyms AKCEA-APOCIII-LRX ALL-P-AMBO-5′-O-(((6-(5-((TRIS(3-(6-(2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYLOXY)HEXYLAMINO)-3-OXOPROPOXYMETHYL))METHYL)AMINO-5-OXOPENTANAMIDO)HEXYL))PHOSPHO)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3

FDA 62

FDA FDA Approval DNA Pharmaceuticals 62

New Drug Approvals

MAY 14, 2025

Food and Drug Administration. 9,13 ]heptacosan-21-yl]oxy]ethyl-trimethylazanium Rezafungin ion Rezafungin cation CD-101 SP-3025 G013B5478J Rezafungin , sold under the brand name Rezzayo (by Melinta Therapeutics), is a medication used for the treatment of invasive candidiasis. [2] 2] [3] CAS No. 18 April 2023.

Pharmacokinetics 62

Pharmacokinetics FDA FDA Approval Treatment 62

Codon

JANUARY 21, 2024

We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. You can do a challenge trial with deadly diseases, but you need a “rescue therapy.” There have been deaths in phase 1 medical and drug research among healthy participants.

Vaccine 131

Vaccine Trials Disease Treatment 131

New Drug Approvals

MAY 30, 2025

1] [7] [8] [9] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [10] Lotilaner CAS 1369852-71-0 Credelio XDEMVY lotilanerum 596.8 1] [7] It is used as an eye drop. [1] 1] It was approved for medical use in the United States in July 2023. [1] 22 February 2024. Retrieved 17 March 2024.

FDA Approval 70

FDA Approval FDA Production International 70

New Drug Approvals

MAY 11, 2025

3] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [9] 2] [5] It is taken by mouth. [2] 5] Omaveloxolone was approved for medical use in the United States in February 2023, [2] [5] [6] [7] [8] and in the European Union in February 2024. [3] 9] SYNTHESIS PATENT Sheikh, AY et al.

FDA 57

FDA FDA Approval Disease Production 57

New Drug Approvals

APRIL 21, 2025

Acoramidis AG-10 1446711-81-4 AG10 Acorami 292.30 1] It is a near-complete (>90%) transthyretin stabilizer, developed to mimic the protective properties of the naturally-occurring T119M mutation, [4] [5] to treat transthyretin amyloid cardiomyopathy.

FDA Approval 62

FDA Approval FDA Production Treatment 62